Welcome to the Board of Medicine.
Due to the current State of Emergency around the COVID-19 Health Advisory, all board and licensing business is being done electronically via email at this time. Please do not call the office or any board phone listed on this page at this time. Please email the Staff listed below and your inquiry will be responded to as soon as possible during normal business hours, Monday-Friday, 8:00am-4:00pm. Thank you for your patience and understanding during this time.
Mission Statement
To protect the public from the unprofessional, incompetent, or impaired practice of medicine.
The Board of Medicine issues licenses to qualified Allopathic and Osteopathic physicians and physician assistants based on nationally recognized credentialing standards. The Board regulates the minimum standards for professional conduct and continued competence and takes disciplinary action against licensees who fail to meet these standards.
Contact the Board
Contact the Board of Medicine.
Mailing Address
State of New Hampshire
Office of Professional Licensure and Certification
Board of Medicine
121 South Fruit Street, Suite 301
Concord, NH 03301-2412
(603) 271-1203 (Main number)
Staff
Pending full license application
Pending locum tenens application
Pending renewal application
Peggy Berube
(603) 271-6935 (phone)
[email protected] (email)
Pending camp application
Sharon Canney
(603) 271-4728 (phone)
[email protected] (email)
Verify a Physician or Physician Assistant license or change of address
Muriel Lariviere
(603) 271-6936 (phone)
[email protected] (email)
Inquiries for the Complaint Department
Victoria Hebert
(603) 271-6930 (phone)
[email protected] (email)
Board Investigator
Victoria Barnard
(603) 271-4161 (phone)
[email protected] (email)
Board Administrator
Penny Taylor
(603) 271-1205 (phone)
[email protected] (email)
Continuing Education
Mary West, CME Coordinator
New Hampshire Medical Society
(603) 224-1909 (phone)
[email protected] (email)
Opioid Prescribing
The board has compiled a list of resources for prescribing opioid for pain management.
NH Prescription Drug Monitoring Program
Legislative Committee Appointments
The Board is looking for volunteers for the following Legislative Committees/Commissions:
- Senate Bill 447 requires the Board to appoint one licensed physician to a commission to study Narcan.
- Senate Bill 523 requires the Board to appoint three licensed physicians, one of whom shall specialize in pain medicine, one of whom shall specialize in addiction medicine and one of whom practices in the field of primary care medicine, to a commission to study requiring controlled drugs and controlled drug analogs to be provided in abuse-deterrent formulation. The Board has already appointed a physician who specializes in pain medicine.
- Senate Bill 135 requires the Board to appoint a pediatric physician licensed under RSA 329 and another pediatric health care provider to a screening commission to assess and recommend measures for preventing childhood lead poisoning and improving screening rates among NH children ages 6 years old and younger.
- Senate Bill 530 requires the Board to appoint a physician assistant to a commission to study volunteer health services.
Declaratory Ruling
COVID-19 – Emergency Rules Adopted
- Med 602.02
file. Revised supervision requirement for Physician Assistants during the pendency of the declared State of Emergency as enacted through Executive Order 2020-04.
Newly Adopted Board Rules:
At its meeting on January 8, 2020, the Board of Medicine adopted Med rules 300-600 , effective January 10, 2020.
Rulemaking Notice
On June 5, 2019, the Board of Medicine voted on an initial proposal for Med 411.02 . The Board originally scheduled a public hearing on this proposal for April 1, 2020. However, due to the COVID-19 state of emergency, the Board has postponed the public hearing until May 6, 2020 at 3:00 p.m.
Persons interested in providing oral testimony on this proposal may do so in person at the public hearing. Written testimony on this proposal will be accepted through the end of the public comment hearing, and may be submitted through mail at the address listed above or via email to [email protected]
